PDB Short entry for 1KPC HEADER PROTEIN KINASE C INTERACTING PROTEIN 06-JAN-96 1KPC TITLE PKCI-1-APO+ZINC COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN PROTEIN KINASE C INTERACTING PROTEIN 1 COMPND 3 (ZINC PROTEIN); COMPND 4 CHAIN: A, B, C, D; COMPND 5 SYNONYM: PKCI-1, PROTEIN KINASE C INHIBITOR 1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HPKCI-1; SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PHIL-D5; SOURCE 9 EXPRESSION_SYSTEM_GENE: HPKCI-1; SOURCE 10 OTHER_DETAILS: EXPRESSED AS AN ACETYLATED PROTEIN ON AMINO SOURCE 11 ACID 2. THIS IS SIMILAR TO THE NATIVE PROTEIN PURIFIED SOURCE 12 DIRECTLY FROM BOVINE BRAIN. KEYWDS PKCI-1, PKC, SIGNAL TRANSDUCTION, ZINC BINDING PROTEIN, KEYWDS 2 PROTEIN KINASE C INTERACTING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.D.LIMA,M.G.KLEIN,I.B.WEINSTEIN,W.A.HENDRICKSON REVDAT 3 24-FEB-09 1KPC 1 VERSN REVDAT 2 01-APR-03 1KPC 1 JRNL REVDAT 1 11-JUL-96 1KPC 0 JRNL AUTH C.D.LIMA,M.G.KLEIN,I.B.WEINSTEIN,W.A.HENDRICKSON JRNL TITL THREE-DIMENSIONAL STRUCTURE OF HUMAN PROTEIN JRNL TITL 2 KINASE C INTERACTING PROTEIN 1, A MEMBER OF THE JRNL TITL 3 HIT FAMILY OF PROTEINS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 93 5357 1996 JRNL REFN ISSN 0027-8424 JRNL PMID 8643579 JRNL DOI 10.1073/PNAS.93.11.5357 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 21145 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.309 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3441 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 294 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 11.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.018 REMARK 3 BOND ANGLES (DEGREES) : 1.97 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.44 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.79 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1KPC COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-SEP-95 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.910 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : FUJI REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36570 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 64.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 6.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.3 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.33000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ACE A 1 REMARK 465 ALA A 2 REMARK 465 ASP A 3 REMARK 465 GLU A 4 REMARK 465 ILE A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 ALA A 8 REMARK 465 GLN A 9 REMARK 465 VAL A 10 REMARK 465 ALA A 11 REMARK 465 ARG A 12 REMARK 465 PRO A 13 REMARK 465 GLY A 14 REMARK 465 GLY A 15 REMARK 465 ACE B 1 REMARK 465 ALA B 2 REMARK 465 ASP B 3 REMARK 465 GLU B 4 REMARK 465 ILE B 5 REMARK 465 ALA B 6 REMARK 465 LYS B 7 REMARK 465 ALA B 8 REMARK 465 GLN B 9 REMARK 465 VAL B 10 REMARK 465 ALA B 11 REMARK 465 ARG B 12 REMARK 465 PRO B 13 REMARK 465 GLY B 14 REMARK 465 GLY B 15 REMARK 465 ACE C 1 REMARK 465 ALA C 2 REMARK 465 ASP C 3 REMARK 465 GLU C 4 REMARK 465 ILE C 5 REMARK 465 ALA C 6 REMARK 465 LYS C 7 REMARK 465 ALA C 8 REMARK 465 GLN C 9 REMARK 465 VAL C 10 REMARK 465 ALA C 11 REMARK 465 ARG C 12 REMARK 465 PRO C 13 REMARK 465 GLY C 14 REMARK 465 GLY C 15 REMARK 465 ACE D 1 REMARK 465 ALA D 2 REMARK 465 ASP D 3 REMARK 465 GLU D 4 REMARK 465 ILE D 5 REMARK 465 ALA D 6 REMARK 465 LYS D 7 REMARK 465 ALA D 8 REMARK 465 GLN D 9 REMARK 465 VAL D 10 REMARK 465 ALA D 11 REMARK 465 ARG D 12 REMARK 465 PRO D 13 REMARK 465 GLY D 14 REMARK 465 GLY D 15 REMARK 465 ASP D 16 REMARK 465 THR D 17 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 16 CB CG OD1 OD2 REMARK 470 ASP B 16 CB CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 87 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 17 -157.13 54.41 REMARK 500 LEU A 90 46.15 -78.41 REMARK 500 ALA B 29 147.56 -171.05 REMARK 500 SER B 45 79.15 -117.71 REMARK 500 ALA B 66 125.36 -37.19 REMARK 500 TYR B 94 -175.29 -179.39 REMARK 500 HIS B 110 110.69 -167.10 REMARK 500 VAL B 111 123.48 -35.41 REMARK 500 THR C 17 -166.69 -114.03 REMARK 500 ASP C 35 -156.01 -141.60 REMARK 500 SER C 45 69.14 -109.69 REMARK 500 HIS C 59 78.27 -66.48 REMARK 500 LEU C 90 65.52 -69.17 REMARK 500 LYS D 30 75.09 -105.98 REMARK 500 SER D 45 65.91 -118.85 REMARK 500 SER D 61 -81.99 -44.98 REMARK 500 LEU D 90 35.87 -82.56 REMARK 500 SER D 102 -73.86 -58.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D 158 DISTANCE = 5.91 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ZNA REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: TRIAD OF HISTIDINES POTENTIALLY INVOLVED IN REMARK 800 ZINC COORDINATION. REMARK 800 SITE_IDENTIFIER: ZNB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: TRIAD OF HISTIDINES POTENTIALLY INVOLVED IN REMARK 800 ZINC COORDINATION. REMARK 800 SITE_IDENTIFIER: ZNC REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: TRIAD OF HISTIDINES POTENTIALLY INVOLVED IN REMARK 800 ZINC COORDINATION. REMARK 800 SITE_IDENTIFIER: ZND REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: TRIAD OF HISTIDINES POTENTIALLY INVOLVED IN REMARK 800 ZINC COORDINATION. DBREF 1KPC A 2 126 UNP P49773 HINT1_HUMAN 1 125 DBREF 1KPC B 2 126 UNP P49773 HINT1_HUMAN 1 125 DBREF 1KPC C 2 126 UNP P49773 HINT1_HUMAN 1 125 DBREF 1KPC D 2 126 UNP P49773 HINT1_HUMAN 1 125 SEQRES 1 A 126 ACE ALA ASP GLU ILE ALA LYS ALA GLN VAL ALA ARG PRO SEQRES 2 A 126 GLY GLY ASP THR ILE PHE GLY LYS ILE ILE ARG LYS GLU SEQRES 3 A 126 ILE PRO ALA LYS ILE ILE PHE GLU ASP ASP ARG CYS LEU SEQRES 4 A 126 ALA PHE HIS ASP ILE SER PRO GLN ALA PRO THR HIS PHE SEQRES 5 A 126 LEU VAL ILE PRO LYS LYS HIS ILE SER GLN ILE SER VAL SEQRES 6 A 126 ALA GLU ASP ASP ASP GLU SER LEU LEU GLY HIS LEU MET SEQRES 7 A 126 ILE VAL GLY LYS LYS CYS ALA ALA ASP LEU GLY LEU ASN SEQRES 8 A 126 LYS GLY TYR ARG MET VAL VAL ASN GLU GLY SER ASP GLY SEQRES 9 A 126 GLY GLN SER VAL TYR HIS VAL HIS LEU HIS VAL LEU GLY SEQRES 10 A 126 GLY ARG GLN MET HIS TRP PRO PRO GLY SEQRES 1 B 126 ACE ALA ASP GLU ILE ALA LYS ALA GLN VAL ALA ARG PRO SEQRES 2 B 126 GLY GLY ASP THR ILE PHE GLY LYS ILE ILE ARG LYS GLU SEQRES 3 B 126 ILE PRO ALA LYS ILE ILE PHE GLU ASP ASP ARG CYS LEU SEQRES 4 B 126 ALA PHE HIS ASP ILE SER PRO GLN ALA PRO THR HIS PHE SEQRES 5 B 126 LEU VAL ILE PRO LYS LYS HIS ILE SER GLN ILE SER VAL SEQRES 6 B 126 ALA GLU ASP ASP ASP GLU SER LEU LEU GLY HIS LEU MET SEQRES 7 B 126 ILE VAL GLY LYS LYS CYS ALA ALA ASP LEU GLY LEU ASN SEQRES 8 B 126 LYS GLY TYR ARG MET VAL VAL ASN GLU GLY SER ASP GLY SEQRES 9 B 126 GLY GLN SER VAL TYR HIS VAL HIS LEU HIS VAL LEU GLY SEQRES 10 B 126 GLY ARG GLN MET HIS TRP PRO PRO GLY SEQRES 1 C 126 ACE ALA ASP GLU ILE ALA LYS ALA GLN VAL ALA ARG PRO SEQRES 2 C 126 GLY GLY ASP THR ILE PHE GLY LYS ILE ILE ARG LYS GLU SEQRES 3 C 126 ILE PRO ALA LYS ILE ILE PHE GLU ASP ASP ARG CYS LEU SEQRES 4 C 126 ALA PHE HIS ASP ILE SER PRO GLN ALA PRO THR HIS PHE SEQRES 5 C 126 LEU VAL ILE PRO LYS LYS HIS ILE SER GLN ILE SER VAL SEQRES 6 C 126 ALA GLU ASP ASP ASP GLU SER LEU LEU GLY HIS LEU MET SEQRES 7 C 126 ILE VAL GLY LYS LYS CYS ALA ALA ASP LEU GLY LEU ASN SEQRES 8 C 126 LYS GLY TYR ARG MET VAL VAL ASN GLU GLY SER ASP GLY SEQRES 9 C 126 GLY GLN SER VAL TYR HIS VAL HIS LEU HIS VAL LEU GLY SEQRES 10 C 126 GLY ARG GLN MET HIS TRP PRO PRO GLY SEQRES 1 D 126 ACE ALA ASP GLU ILE ALA LYS ALA GLN VAL ALA ARG PRO SEQRES 2 D 126 GLY GLY ASP THR ILE PHE GLY LYS ILE ILE ARG LYS GLU SEQRES 3 D 126 ILE PRO ALA LYS ILE ILE PHE GLU ASP ASP ARG CYS LEU SEQRES 4 D 126 ALA PHE HIS ASP ILE SER PRO GLN ALA PRO THR HIS PHE SEQRES 5 D 126 LEU VAL ILE PRO LYS LYS HIS ILE SER GLN ILE SER VAL SEQRES 6 D 126 ALA GLU ASP ASP ASP GLU SER LEU LEU GLY HIS LEU MET SEQRES 7 D 126 ILE VAL GLY LYS LYS CYS ALA ALA ASP LEU GLY LEU ASN SEQRES 8 D 126 LYS GLY TYR ARG MET VAL VAL ASN GLU GLY SER ASP GLY SEQRES 9 D 126 GLY GLN SER VAL TYR HIS VAL HIS LEU HIS VAL LEU GLY SEQRES 10 D 126 GLY ARG GLN MET HIS TRP PRO PRO GLY FORMUL 5 HOH *294(H2 O) HELIX 1 1 THR A 17 ILE A 23 1 7 HELIX 2 2 ILE A 63 VAL A 65 5 3 HELIX 3 3 ASP A 68 ASP A 87 5 20 HELIX 4 4 GLY A 101 GLY A 104 1 4 HELIX 5 5 ILE B 18 ILE B 23 1 6 HELIX 6 6 ASP B 68 ASP B 87 5 20 HELIX 7 7 ILE C 18 ILE C 23 1 6 HELIX 8 8 ILE C 63 VAL C 65 5 3 HELIX 9 9 ASP C 68 ASP C 87 5 20 HELIX 10 10 PHE D 19 ILE D 23 1 5 HELIX 11 11 ILE D 63 VAL D 65 5 3 HELIX 12 12 ASP D 68 ASP D 87 5 20 HELIX 13 13 GLY D 101 GLY D 104 1 4 SHEET 1 A10 ILE B 31 GLU B 34 0 SHEET 2 A10 CYS B 38 HIS B 42 -1 N ALA B 40 O ILE B 32 SHEET 3 A10 THR B 50 PRO B 56 -1 N ILE B 55 O LEU B 39 SHEET 4 A10 HIS B 112 GLY B 117 -1 N GLY B 117 O THR B 50 SHEET 5 A10 TYR B 94 GLY B 101 -1 N VAL B 97 O HIS B 114 SHEET 6 A10 GLY A 93 GLU A 100 -1 N GLU A 100 O TYR B 94 SHEET 7 A10 HIS A 112 GLY A 117 -1 N LEU A 116 O ARG A 95 SHEET 8 A10 THR A 50 PRO A 56 -1 N VAL A 54 O LEU A 113 SHEET 9 A10 CYS A 38 HIS A 42 -1 N PHE A 41 O LEU A 53 SHEET 10 A10 ILE A 31 GLU A 34 -1 N PHE A 33 O ALA A 40 SHEET 1 B10 ILE D 31 GLU D 34 0 SHEET 2 B10 CYS D 38 HIS D 42 -1 N ALA D 40 O ILE D 32 SHEET 3 B10 THR D 50 PRO D 56 -1 N ILE D 55 O LEU D 39 SHEET 4 B10 HIS D 112 GLY D 117 -1 N GLY D 117 O THR D 50 SHEET 5 B10 TYR D 94 GLU D 100 -1 N VAL D 97 O HIS D 114 SHEET 6 B10 TYR C 94 GLU C 100 -1 N GLU C 100 O TYR D 94 SHEET 7 B10 HIS C 112 GLY C 117 -1 N LEU C 116 O ARG C 95 SHEET 8 B10 THR C 50 PRO C 56 -1 N VAL C 54 O LEU C 113 SHEET 9 B10 CYS C 38 HIS C 42 -1 N PHE C 41 O LEU C 53 SHEET 10 B10 ILE C 31 GLU C 34 -1 N PHE C 33 O ALA C 40 CISPEP 1 TRP A 123 PRO A 124 0 0.68 CISPEP 2 TRP B 123 PRO B 124 0 0.45 CISPEP 3 TRP C 123 PRO C 124 0 0.37 CISPEP 4 TRP D 123 PRO D 124 0 -0.15 SITE 1 ZNA 3 HIS A 51 HIS A 112 HIS A 114 SITE 1 ZNB 3 HIS B 51 HIS B 112 HIS B 114 SITE 1 ZNC 3 HIS C 51 HIS C 112 HIS C 114 SITE 1 ZND 3 HIS D 51 HIS D 112 HIS D 114 CRYST1 63.940 78.660 46.310 90.00 90.00 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015640 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012713 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021594 0.00000